Preclinical
The two companies will work on a preclinical target in hopes of finding new therapies for autoimmune diseases that regulate immune cell metabolism.
The study will focus on whether or not treatment with progesterone will counter-act the first dose of a chemical-induced abortion medication.
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
The research has broad potential for targeted treatments for neurological diseases like epilepsy or for pain treatment. Their research was published in the journal Science.
As the American College of Cardiology (ACC) annual meeting opens in New Orleans this weekend, one of the big stories will undoubtedly be on the role of wrist sensors, such as the Apple Watch, in identifying heart rhythm problems. There will be other big stories, of course. Here’s a preview of just a couple.
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
The study tracked more than 250 veterans in over 600 visits at the Richard L. Roudebush VA Medical Center in Indianapolis, attempting to identify a molecule in the blood to track stress intensity. Over a decade, they evaluated gene expression in participants in both low- and high-stress states.
Data demonstrate platform feasibility to rapidly generate novel ADC combinations with superior stability
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
This year could be the big year for the company. Its chief executive officer and president, Isaac Ciechanover, is leaving the company by June 30, but says 2019 could be transformative.
PRESS RELEASES